We have shown recently that the human poliovirus receptors (hPVRs) expressed on the surface of cultured cells are 80K glycoproteins, whereas the previously reported 67K forms are partially glycosylated intermediate glycoforms. Both the membrane-bound 80K and 67K forms of hPVR are glycosylated derivatives of the two isoforms hPVR~ and hPVR6, where the latter two can be resolved only by SDS-PAGE upon enzymatic deglycosylation. Here we report the N-terminal sequence analysis of the mature 80K as well as the intermediate 67K glycoforms of hPVR which has allowed us to identify the signal peptidase cleavage site of the unprocessed hPVR. The signal sequence that directs translocation of hPVR across the membrane of the endoplasmic reticulum on its route to the glycoprocessing pathway has thus been defined. We compare this signal sequence with those of the putative monkey poliovirus receptor and the mouse poliovirus receptor homologue.
Introduction
Expression of poliovirus receptors (PVRs) on mammalian cells is a prerequisite for poliovirus infection. Only primates express PVR, the normal cell function of which is unknown. For the virus to enter the cell, and to initiate a productive round of propagation, it must first bind to PVR on the cell surface (Crowell & Landau, 1983; Lonberg-Hotm & Philipson, 1981; Tardieu et al., 1982) . This was demonstrated by engineered expression of PVR in non-primate cells and their subsequent susceptibility to poliovirus infection (Bernhardt et al., 1994; Koike et al., 1990; Mendelsohn et al., 1989) . Poliovirus infection is tissue type-specific in humans. However, some form of constraint is removed when tissue cells are propagated in culture. Many types of cells from human tissue do not bind virus until grown either as a primary culture or as a transformed cell line, after which they are susceptible to virus infection (Holland, 1961) .
PVR is a type Ia single-pass transmembrane glycoprotein (Singer, 1990) . Sequence alignments suggest that PVR is a member of the immunoglobulin superfamily with three extracellular immunoglobulin-like lPresent address: Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York 10021-6399, U.S.A.
domains: V2-C2-C2. Human PVRs (hPVRs) have eight potential N-glycosylation sites (Koike et al., 1991; Mendelsohn et al., 1989) . The first V2-1ike domain was shown to be necessary and sufficient for interaction with the virus (Koike et al., 1991 ; Selinka et al., 1991 Selinka et al., , 1992 . Indeed, the V2 domain can be spliced onto a truncated heterologous cell surface glycoprotein (ICAM-1) whereby the hybrid molecule facilitates virus attachment and productive uptake . cDNA analysis revealed that the hPVR gene encodes four different isoforms. Two of the isoforms are membranebound and differ only in the amino acid sequence of their cytoplasmic tail; hPVR~ has 50 cytoplasmic amino acids and hPVR6 has 25 cytoplasmic amino acids (Koike et al., 1990; Mendelsohn et al., 1989) . The other two splice variants, hPVRfl and hPVRy, lack the transmembrane exon and, therefore, code for secreted proteins (Koike et al., 1990) .
Two genes were found to encode three splice variant monkey PVR (mPVR) mRNAs. Two of these, mPVR~I and mPVR61, are homologous to hPVR~ and hPVR6 but encode one less glycosylation site in domain 2. The third mRNA species is transcribed from the second genetic locus and encodes isoform mPVR~2 which lacks the two glycosylation sites in domain 1 as well as one site in domain 2 (Koike et al., 1992) . The expression pattern of mPVR has not been reported and hence the significance of these findings is not known.
A murine homologue of PVR (MPH) has been identified which does not function as a receptor for poliovirus, not even for type 2 (Lansing), a virus strain known to cause neurological disease in mice (Morrison & Racaniel]o, 1992) .
hPVR was first reported to have an M r of 67K when different membrane-bound hPVR isoforms were expressed using vaccinia virus (hPVRa) , baculovirus (hPVR6) (Kaplan et al., 1990) , or in vitro translation in rabbit reticulocyte lysate in the presence of dog pancreatic microsomes (hPVRa) . However, deglycosylation experiments suggested that the previously reported 67K form expressed by a recombinant vaccinia virus is an intracellular high-mannose glycosylation intermediate. In contrast, mature membrane-bound forms of hPVR possessing complex branched chain oligosaccharides appeared as broad 80K bands after SDS-PAGE (Bernhardt et al., 1994) . The mPVR occurs also as a broad band with a lower Mr of about 70K (Bernhardt et al., 1994) .
Here we report an analysis of the N-terminal sequence of the 80K and 67K forms of hPVR. We have radiolabelled cells with specific essential amino acids and purified the two respective forms of hPVR by immunoprecipitation and gel electrophoresis. Edman degradation of this material yielded identical N-terminal amino acid sequence data for both the 67K and 80K glycoforms. Alignment of the N-terminal sequence with the predicted hPVR amino acid sequence allowed us to define the signal sequence of the pre-hPVR proteins and to compare it with the deduced N-terminal sequences of pre-mPVRs and pre-MPH.
Methods
Tissue culture. HeLa R19 monolayers were grown in DMEM, 10 % bovine calf serum (BCS). JA-1 cells, derived from mouse fibroblast cells stably transfected with a cosmid clone encompassing the hPVR gene as previously described (Bernhardt et al., 1994) , were grown as monolayers in DMEM, 10% BCS, HAT.
Vaccinia virus infection of HeLa ceils.
HeLa cells were co-infected with vVTFT-3, a recombinant vaccinia virus which expresses the T7 polymerase (Fuerst et al., 1987) , and vvPVR, a recombinant vaccinia virus in which hPVR~ expression is driven by the T7 bacteriophage promoter . The m.o.i, for both viruses in the coinfection was 10. The frozen and thawed supernatant fraction of a vaccinia virus preparation grown in HeLa cells was added directly to the culture media to initiate HeLa cell infection. The culture was then incubated for the indicated period of time in the presence of radiolabelled essential amino acids as described below.
Immunoprecipitation. All immunoprecipitations were conducted as previously described (Bernhardt et al., 1994) . Briefly, an excess of the anti-hPVR monoclonal antibody (MAb) p44 [a gift of A. Nomoto (Koike et aL, 1990) ] was preloaded onto Protein A-Sepharose (Pharmacia) overnight. The beads were then washed and diluted to about 15:1 with a 50% suspension of Sephadex G50 equilibrated in PBS. This material was stored at 4 °C and used as needed, Generally, 107 cultured monolayer cells which had been metabolically labelled with essential amino acids were scraped, dispersed, washed with PBS, and lysed in 1 ml of 0.5% NP40 in PBS at 4 °C. Insoluble cell debris was removed by centrifugation and 25 ktl of the loaded resin was added. After incubation overnight, the resin was washed three times with PBS. The samples were then boiled in 30 lal 10% SDS and 25 mM-2-flmercaptoethanol.
Analytical and preparative SDS PAGE and membrane transfer.
Loading buffer was added to samples to be analysed or fractionated by 12"5 % gel electrophoresis and SDS-PAGE was performed according to the method of Laemmli (1970) . For analytical gels, fixation in 20 % acetic acid, 50% methanol was followed by enhancement in 1 r~i-sodium salicylate for 1 h, drying and exposure to X-ray film. For preparative gels, electrophoresis was followed by horizontal transfer to Immobilon-P nitrocellulose (Millipore) membrane according to the Western blotting protocol provided by Sambrook et al. (1989) . This membrane was washed in 50% methanol, air-dried and exposed to Xray film with chemoluminescent markers for orientation. The developed film was then used as a template to excise the corresponding radiolabelled protein of interest for radioactive amino acid sequence analysis.
Radiolabelling. Methionine-free medium was obtained in fully constituted form (BRL) and threonine-and valine-free media were prepared using the Select-Amine Kit (BRL). Protein sequencing. For the immunoprecipitated 67K form of hPVR labelled with [3H]valine, SDS-PAGE-fractionated protein which had been transferred to a Millipore Immobilon-P nitrocellulose transfer membrane was processed by an Applied Biosystems Model 475A protein sequencer with an on-line Model 128 PTH analyser. The resulting fractions representing sequential Edman degradation cycles were analysed in a Packard 1900TR liquid scintillation counter with nuclide-specific parameters and repetitive 10 min counting periods.
All other immunoprecipitated labelled hPVR samples were applied directly to Prospin sample preparation cartridges in which the proteins were bound onto ProBlott PVDF membranes (Applied Biosystems). The membranes were analysed for amino acid sequences as described above.
Results and Discussion
Expression of the 67K and 80K glycoforms of hPVR As previously described (Bernhardt et al., 1994) , coinfection of HeLA cells with the recombinant vaccinia viruses vvPVR (encoding hPVR~ driven by the T7 promoter) and vVTF7-3 (encoding T7 RNA polymerase), (Fuerst et al., 1987) respectively, resulted in the expression of 80K and 67K hPVR proteins that were immunoprecipitated from [35S]methionine-labelled cell lysates at 6 h post-infection (p.i.) (Fig. 1, lane 1) . In contrast, only the 67K protein is i m m u n o p r e c i p i t a t e d if radiolabelling is carried out 18 h p.i. (Fig. 1, lane 2) . Therefore we concluded that vaccinia virus infection continued into late stages has deleterious effects on the glycoprocessing p a t h w a y (Bernhardt et al., 1994) . with the functional gene for h P V R ; they express the two m e m b r a n e -a s s o c i a t e d splice variants mentioned above (Bernhardt et al., 1994) .
W e were interested to k n o w whether the 80K and 67K forms o f hPVR, a p a r t from similar i m m u n o l o g i c a l properties, shared the same N -t e r m i n a l amino acid sequence. Whereas h P V R is clearly visible as a specific b a n d with a relatively low b a c k g r o u n d from i m m u n oprecipitations o f aaS-labelled lysates, the absolute quan- tity o f protein is small and below the level of detection using s t a
n d a r d m e t h o d s such as a Bradford assay and s p e c t r o p h o t o m e t r y ( < 1 gg) ( S a m b r o o k et al., 1989).
This m a d e it impossible to purify enough unlabelled proteins for direct sequencing. Therefore we labelled cells expressing one hPVR form or the other with specific essential amino acids which were known, from the deduced amino acid sequence, to occur close to the position of the previously predicted N terminus of the mature hPVR proteins (Mendelsohn et al., 1989) •
Amino acid sequencing of hPVR 67K and 80K forms
At least 500 to 1000c.p.m./residue of material is generally needed for N-terminal amino acid analysis. Since hPVRc¢ has 40 valine residues and 31 threonine residues, this corresponds to a minimum requirement of 20000 c.p.m, of total valine label and 15 500 c.p.m, of total threonine label per analysed sample. Fifty-thousand total [3H]valine c.p.m, were immunoprecipitated specifically from a HeLa cell lysate infected with vvPVR/vVTF7-3. All of this material was fractionated by SDS-PAGE as shown in Fig. 2(a, lane 1) , and the hPVR-related proteins were transferred electrophoretically to nitrocellulose. The region of the filter corresponding to the 67K band was excised and a small portion of the bound material was analysed by liquid scintillation counting. The results indicated that the sample contained 30000 total c.p.m. (750 c.p.m./valine residue). This sample was then subjected to automated Edman degradations and the resulting fractions were analysed by liquid scintillation counting. The results are shown in Fig. 3 (a) . The valine peaks at cycles 2, 3, 4 and 10 align with the deduced amino acid sequence at the Nterminal portion of pre-hPVR as shown in Fig. 3(a) (bottom), which indicates that the N-terminal amino acid of the 67K glycoform is aspartic acid (see also Fig. 2(a, lanes 3  and 4) . Since the vast majority of label was associated with the specific 67K band, the preparative SDS PAGE transfer step was omitted in this case. The 3H-and 14C-labelled material was combined and directly bound to a nitrocellulose membrane filter. The sample was then analysed for amino acid sequence. The results are shown in Fig. 3(b) . The threonine peak at position 8 can be aligned with the N-terminal amino acid sequence of the 67K protein shown in Fig. 4(a) confirming aspartic acid at position 28 to be the N terminus of the mature form of hPVR0¢.
Only 23000 specific total [3H]threonine counts (742 c.p.m./threonine residues) corresponding to the (8 residues) (11 residues) (8 residues)
Alignment of pre-hPVR, pre-mPVR and pre-MPH signal sequences n-region h-region c-region endogenous 80K form of hPVR could be immunoprecipitated from labelled JA-1 cell lysate and a portion of this sample appears as a faint band in Fig. 2 (b,  lane 3) . This material was processed as described above for the aH/l~C-threonine labelled 67K form produced by the vaccinia virus expression system. The resulting amino acid sequencing analysis data shown in Fig. 3 (c) display a profile related to that generated for the 67K form of hPVR.
It should be noted that the persistence of radioactivity from cycles succeeding that of the threonine at position 8 as well as valine at position 10 of mature hPVR is attributable to the proline at position 7. In the Edman degradation reaction the secondary amino group (an imino group) of proline functions as a less reactive nucleophile compared to the other N-terminal amino acids. Cycles subsequent to proline release will therefore commonly reflect this inefficiency in removal as a diminished decrease in counts following the position of a labelled amino acid.
Hence these data support the postulate that both the 80K and 67K forms of hPVR have the same N-terminal amino acid composition. Our findings of aspartic acid being the N-terminal amino acid of mature hPVR is at variance with the previously suggested N terminus being tryptophan at position 21 (Mendelsohn et al., 1989) .
We have reported that N-deglycosylation of the 80K forms of hPVR resulted in proteins of 47K and 43K upon SDS-PAGE analysis which correspond to the hPVR isoforms ~ and 3, respectively. JA-1 cells express equal amounts of each of these proteins (Bernhardt et al., 1994) . The results reported here suggest that the two membrane-bound isoforms hPVR~ and hPVR6 possess identical N-terminal amino acid sequences since the degradation profile of hPVR from JA-1 cells (Fig. 3 c) is the same as that for hPVR~ expressed by the recombinant vaccinia virus vvPVR (Fig. 4b) .
The signal sequence of hPVR and its homologues
Alignment of the sequencing data with the deduced amino acid sequence at the N terminus of hPVR indicated that aspartic acid at position 28 of the unprocessed form of hPVR (pre-hPVR) is the first Nterminal amino acid of the mature form of hPVR. The signal sequence of hPVR is therefore 27 amino acids long (Fig. 4a) .
For comparison the pre-hPVR signal sequence is shown in alignment with the predicted signal sequences of the other PVR homologues in Fig. 4(b) . The signal peptide can be divided into three distinct regions: the positively charged n-region, the central h-region (hydrophobic core enriched in hydrophobic amino acids) and the c-region (containing relatively polar amino acids and often including proline and glycine) (von Heijne, 1985) . The signal sequences of pre-hPVR as well as those predicted for its homologues are unusually long with the 31 residue pre-MPH signal being somewhat extraordinary when compared to the average length (18 to 20 residues) (yon Heijne, 1985) .
Average hydrophobicity values can be calculated for the h-region based on a variety of scales (Hopp & Woods, 1981; Levitt, 1976; Rose et al., 1985; Sweet & Eisenberg, 1983) . These values have been shown to correlate with translocation efficiency (Bird et al., 1990) . The average hydrophobicities of the h-regions of prehPVR and pre-MPH are remarkably similar and would correlate to a translocation efficiency of greater than 90% in one such analysis (Bird et al., 1990; Doud et al., 1993) . On the other hand, the hydrophobic character of the h-regions of the pre-mPVRs is suboptimal. This is particularly true for the h-region of pre-mPVRal/61 which falls short of the minimal requirements of a signal peptide h-region as defined by yon Heijne (1985) .
The experimentally determined signal peptidase cleavage site (G+D) is also predicted by theoretical considerations (yon Heijne, 1983 (yon Heijne, , 1986 . The corresponding aspartic acids at position 28 and 24 of premPVRa/61 and pre-mPVRe2, respectively, are predicted to be the N-terminal amino acids whereas the glutamine at position 32 is predicted to be the N terminus of mature MPH.
It will be interesting to learn whether differences in signal sequences of mPVRs lead to differences in tissuespecific expression. This may have a bearing on the normal cellular functions, particularly in the case of mPVRgl/61 and mPVRg2 which possess different putative glycosylation patterns in the V2 domains and slightly divergent amino acid sequences (Koike et al., 1990) .
